ROLE OF WITHANIA SOMNIFERA IN PREVENTION AND TREATMENT OF CANCER: AN OVERVIEW
Abstract
Cancer is hyperproliferative disorder that involves transformation, dysregulation of apoptosis, proliferation, invasion, angiogenesis and metastasis. Millions of people die every year with different types of cancer such as lung cancer and mesothelioma from inhaling asbestos fibers and tobacco smoke, or leukemia from exposure to benzene at their workplaces. In the last century, great advances were made in modern medical system in cure and prevent of this disease. However, success rates are very low. Withania somnifera (WS) has been used as traditional medicine for decades for the treatment of various ailments. The various parts of WS and its constituents are effective in prevention and treatment of different kinds of cancer like colon cancer, lung cancer, blood cancer, skin cancer, breast cancer, renal cancer, fibrosarcoma, prostate cancer, pancreatic cancer. We are conducting clinical studies to prove the efficacy of WS in prevention and treatment of different forms of cancer including prostate and lung cancers, especially in last stages, and this wonder medicinal herb is found to be beneficial in many patients. We have some cases of lung cancer that were refused modern therapy and recovered clinically and radiologically with our therapy of Ashwagandha. Clinical studies suggest its use as anti-tumor and immunomodulatory agent in sarcoma, brain cancer, uterine tumor, fibroids and other tumors including endodermal carcinoma. Therefore, this medicinal herb WS alone can be used as alternative medicine in the treatment of cancer patients or it can also be used as adjunct/ complimentary medicine along with chemotherapy or radiotherapy to patients. As the causative factors in formation and development of cancerous conditions can be multifactorial eg. stress- physical, chemical, biological and emotional, viral infection like Herpes cause several time more cancer of bladder, low immune syndrome plays major role in spread and causation of cancer, environmental chemical toxins, allopathic drugs, pesticide infected food with heavy metals and some not properly developed metallic preparation of Ayurvedic or other Folk Medicine can be a causative factor, leave aside genetic processes of the Individual for the development of the risk of cancer. If we look in the properties of WS like adaptogen/ anti-stress agent, immunomodulator, antioxidant (reducing free radical damage, anabolic effect, improving resistance of body, reducing fatigue and detoxificant effects, we are inclined to suggests that WS works through all above mechanisms in controlling the dreaded cancer, rather than its effect on stopping the cell division. As during radio and chemotherapy body’s natural normal cells are also killed and low immunity develops, WS helps prevent these adverse effects of both and helps patients better recovery and life styles. However, multicentric long term clinical studies by oncologists, although deviated from their routine, must be carried out on WS to prove our contentions.
Keywords:
Withania somnifera, withaferin A, colon cancer, lung cancer, blood cancer, skin cancer, breast cancer, renal cancer, fibrosarcoma, prostate cancer, pancreatic cancer.DOI
https://doi.org/10.25004/IJPSDR.2011.030401References
2. World Health Organization (2007-04-27). "WHO calls for prevention of cancer through healthy workplaces" Press release. Retrieved 2007-10-13.
3. Mayola E, Gallerne C, Esposti DD, Martel C, Pervaiz S, Larue L, Debuire B, Lemoine A, Brenner C, Lemaire C. Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2. Apoptosis 2011; 16(10):1014-1027.
4. Mirjalili MH, Moyano E, Bonfill M, Cusido RM, Palazón J. Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules. 2009; 14 (7): 2373–93.
5. Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera. (Ashwagandha): A review. Alternative Medicine Reviews 2000; 5: 334-46.
6. Bhattacharya SK, Goel RK, Kaur R., Ghosal S. Anti - stress activity of Sitoindosides VII and VIII, New Acylsterylglucosides from Withania somnifera. Phytother. Res. 1987; 1: 32-37.
7. Ghosal S, Srivastava RS, Bhattacharya SK, Upadhyay SN, Jaiswal AK, Chattopadhyay U. Immunomodulatory and CNS effects of sitoindosides IX and X, two new glycowithanolides form Withania somnifera. Phytother. Res. 1989; 2: 201–206.
8. Rahman A, Abbas S, Shahwar D, Jamal SA, Choudhary MI, Abbas S. New withanolides from Withania spp. Journal of Natural Products 1991; 56: 1000–1006.
9. Muralikrishnan G, Dinda AK, Shakeel F. Immunomodulatory effects of Withania somnifera on azoxymethane induced experimental colon cancer in mice. Immunol Invest. 2010; 39(7):688-98.
10. Muralikrishnan G, Amanullah S, Basha MI, Dinda AK, Shakeel F. Modulating effect of Withania somnifera on TCA cycle enzymes and electron transport chain in azoxymethane-inducedcolon cancer in mice. Immunopharmacol Immunotoxicol. 2010; 32(3):523-527.
11. Koduru S, Kumar R, Srinivasan S, Evers MB, Damodaran C. Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis. Mol Cancer Ther. 2010 Jan; 9(1):202-10.
12. Jayaprakasam B, Zhang Y, Seeram NP, Nair MG. Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves. Life Sci. 2003; 74(1):125-32.
13. Yadav B, Bajaj A, Saxena M, Saxena AK. In Vitro Anticancer Activity of the Root, Stem and Leaves of Withania Somnifera against Various Human Cancer Cell Lines. Indian J Pharm Sci. 2010; 72(5): 659-663.
14. Singh N, Singh SP, Nath R, Singh DR, Gupta ML, Kohli RP, Bhargava KP. Prevention of urethane induced Lung adenomas by Withania somnifera (L) Dunal in albino mice. Int J of Crude Research 1986; 24(2):90-100.
15. Thaiparambil JT, Bender L, Ganesh T, Kline E, Patel P, Liu Y, Tighiouart M, Vertino PM, Harvey RD, Garcia A, Marcus AI. Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine56 phosphorylation. Int J Cancer 2011.
16. Anon Monograph. Withania somnifera. Altern Med Rev. 2004; 9(2):211-214.
17. Senthilnathan P, Padmavathi R, Magesh V, Sakthisekaran D. Chemotherapeutic efficacy of paclitaxel in combination with Withania somnifera on benzo(a)pyrene-induced experimental lung cancer. Cancer Sci. 2006; 97(7):658-64.
18. Senthilnathan P, Padmavathi R, Banu SM, Sakthisekaran D. Enhancement of antitumor effect of paclitaxel in combination with immunomodulatory Withania somnifera on benzo(a)pyrene induced experimental lung cancer. Chem Biol Interact. 2006; 159(3):180-185.
19. He QP, Ma L, Luo JY, He FY, Lou LG, Hu LH. Cytotoxic withanolides from Physalis angulata L. Chem Biodivers. 2007; 4(3):443-9.
20. Malik F, Kumar A, Bhushan S, Khan S, Bhatia A, Suri KA, Qazi GN, Singh J. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis 2007; 12(11):2115-2133.
21. Mondal S, Mandal C, Sangwan R, Chandra S, Mandal C. Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. Mol Cancer. 2010; 9:239.
22. Oza VP, Parmar PP, Kumar S, Subramanian RB. Anticancer properties of highly purified L-asparaginase from Withania somnifera L. against acute lymphoblastic leukemia. Appl Biochem Biotechnol. 2010; 160(6):1833-1840.
23. Padmavathi B, Rath PC, Rao AR, Singh RP. Roots of Withania somnifera Inhibit Forestomach and Skin Carcinogenesis in Mice. Evid Based Complement Alternat Med. 2005; 2(1):99-105.
24. Mathur S, Kaur P, Sharma M, Katyal A, Singh B, Tiwari M, Chandra R. The treatment of skin carcinoma, induced by UV B radiation, using 1-oxo-5beta, 6beta-epoxy-witha-2-enolide, isolated from the roots of Withania somnifera, in a rat model. Phytomedicine. 2004; 11(5):452-460.
25. Prakash J, Gupta SK, Dinda AK. Withania somnifera root extract prevents DMBA-induced squamous cell carcinoma of skin in Swiss albino mice. Nutr Cancer. 2002; 42(1):91-7.
26. Davis L, Kuttan G. Effect of Withania somnifera on DMBA induced carcinogenesis. J Ethnopharmacol. 2001; 75(2-3):165-168.
27. Hahm ER, Lee J, Huang Y, Singh SV. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells. Mol Carcinog. 2011; 50(8):614-624.
28. Lee J, Hahm ER, Singh SV. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells. Carcinogenesis 2010; 31(11):1991-1998.
29. Mulabagal V, Subbaraju GV, Rao CV, Sivaramakrishna C, Dewitt DL, Holmes D, Sung B,Aggarwal BB, Tsay HS, Nair MG. Withanolide sulfoxide from Aswagandha roots inhibits nuclear transcription factor-kappa-B, cyclooxygenase and tumor cell proliferation. Phytother Res. 23(7):987-992.
30. Yang ES, Choi MJ, Kim JH, Choi KS, Kwon TK. Withaferin A enhances radiation-induced apoptosis in Caki cells through induction of reactive oxygen species, Bcl-2 downregulation and Akt inhibition. Chem Biol Interact. 2011; 190(1):9-15.
31. Choi MJ, Park EJ, Min KJ, Park JW, Kwon TK. Endoplasmic reticulum stress mediates withaferin A-induced apoptosis in human renal carcinoma cells. Toxicol In Vitro. 2011; 25(3):692-698.
32. Kaileh M, Vanden Berghe W, Boone E, Essawi T, Haegeman G. Screening of indigenous Palestinian medicinal plants for potential anti-inflammatory and cytotoxic activity. J Ethnopharmacol. 2007; 113(3):510-516.
33. Prakash J, Gupta SK, Kochupillai V, Singh N, Gupta YK, Joshi S. Chemopreventive activity of Withania somnifera in experimentally induced fibrosarcoma tumours in Swiss albino mice. Phytother Res. 2001; 15(3):240-244.
34. Davis L, Kuttan G. Effect of Withania somnifera on 20-methylcholanthrene induced fibrosarcoma. J Exp Clin Cancer Res. 2000 Jun; 19(2):165-167.
35. Yadav B, Bajaj A, Saxena M, Saxena AK. In Vitro Anticancer Activity of the Root, Stem and Leaves of Withania Somnifera against Various Human Cancer Cell Lines. Indian J Pharm Sci. 2010; 72(5):659-663.
36. Yu Y, Hamza A, Zhang T, Gu M, Zou P, Newman B, Li Y, Gunatilaka AA, Zhan CG, Sun D. Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochem Pharmacol. 2010; 79(4):542-551.
37. Kathy C, Bedker D, Roussel P. "Myocardial Infarction: Review of Clinical Trials and Treatment Strategies." Critical Care Nurse. 1998; 18(2):39–51.
38. Moritz A. Cancer is not a disease. 2nded. USA: Ener-Chi Wellness Press, 2008. pp. 21-23.
39. Sharma CG. Ashwagandharishta – Rastantra Sar Evam Sidhyaproyog Sangrah-Krishna- Gopal Ayurveda Bhawan (Dharmarth Trust), Nagpur, 1938, pp. 743-744.
40. Chatterjee A, Pakrashi SC. The Treatise on Indian Medicinal Plants 1995; 4:208-212.
41. Bone K. Clinical Applications of Ayurvedic and Chinese Herbs. Monographs for the Western Herbal Practitioner. Australia. Phytotherapy Press. 1996; 137-141.
42. Singh N, Agarwal AK, Lata A, Kohli RP. Evaluation of Adaptogenic properties of Withania somnifera. Proc Ind Pharmacol Soc. 1976, pp. 21.
43. Singh N, Agarwal AK, Lata A, Kohli RP. Experimental evaluation of 'adaptogenic' properties of Withania somnifera. In the Proceeding of the XIIth Scientific Seminar on Indian Medicine, Institute of Medical Sciences. Varanasi. 1977, pp. 4.
44. Singh N, Singh SP, Sinha JN, Shanker K, Kohli RP. Withania somnifera (Ashwagandha) A rejuvenator herbal drug which enhances survival during stress (An adaptogen). Int. J. Crude Res. 1982; 3: 29-35.
45. Singh N. A pharmacoclinical evaluation of some ayurvedic crude plant drugs as antistress agents and their usefulness in some stress diseases of man. Ann Nat Acad Ind Med. 1986; 2(1): 14-26.
46. Davis L, Kuttan G. Effect of Withania somnifera on cell mediated immune responses in mice. J Exp Clin Cancer Res. 2002; 21(4): 585-590.
47. Bhattacharya A, Ghosal S, Bhattacharya SK. Antioxidant effect of Withania somnifera glycowithanolides in chronic foodshok stress induced perturbation of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. J Ethanopharmacol. 2001; 74(1): 1-6.
48. Bhattacharya S, Satyan KS, Ghosal S. Antioxidant activity of glycowithanolides from Withania somnifera. Ind J Exp Biol. 1997; 35(3):236-239.
49. Singh B, Saxena AK, Chandan BK, Gupta DK, Bhutani KK, Anand KK. Adaptogenic activity of a novel withanolide-free aqueous fraction from the roots of Withania somnifera. Dun Phytother Res. 2001; 15(4): 311-318.
50. Kaur K, Rani G, Widodo N, Nagpal A, Taira K, Kaul SC, Wadhva R. Evaluation of the anti proliferative and antioxidative activity of leaf extract from in vivo and in vitro raised Ashwagandha. Food Chem Toxicol. 2004; 42 (12): 2015-2020.
51. Nagashayana N, Sankarankutty P, Nampoothiri MR, Mohan PK, Mohan Kumar KP. Association of M Dopa with recovery following Ayurveda medication in Parkinson Disease. J Neurol Sci. 2000; 176 (2):124-127.
52. Ahmad M, Saleem S, Ahmad AS, Ansari MA, Yusuf S, Hoda MM, Islam F. Neuroprotective effect of Withania somnifera on 6- hydroxydopamine indused Parkinsonism in rat. Hum Exp Toxicol, 2005; 24(3):137-147.
53. Singh SP, Singh DR, Gupta ML, Singh N, Kohli RP, An experimental Evaluation of Anti Tumor activity of Withania somnifera (Ashwagandha) and “Geriforte” Proc. XI Annual Conf of Ind Pharmacol Sos. 1979; 11(1):65.
54. Panda S, Kar A. Withania somnifera and Bauhinia pupurea in the regulation circulating thyroid hormone concentration in female mice. J Ethanopharmacol. 1999; 67: 233-239.
55. Singh N, Gilca M. Herbal Medicine – Science embraces tradition – a new insight into the ancient Ayurveda. Lambert Academic Publishing (Germany), 2010, pp. 51-67.
56. Singh N, Bhalla M, Jager P, Gilca M. An Overview on Ashwagandha: A Rasayana (Rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med. 2011; 8(S):208-213.
Published
Abstract Display: 544 
PDF Downloads: 407 
